Authors contributions Conception of the consensus statement: ADO, LJO, JIMA, BJS, DLH Data extraction: LJO, AS, JMIA, KDK, ES, CRFR, RC Interpretation of data: ADO, LJO, BJS, AS, JMIA, KDK, ES, CRFR, RC, MDHA, CEM, MC, RM, GEU, DLH Writing the manuscript: ADO, LJO, AS, JMIA, MDHA, KDK, ES, CRFR, RC Revising the manuscript for important intellectual content: ADO, BJS, MC, RM, GEU, DLH Declarations of interest GEU receives grant support from Novo Nordisk, Merck, Insulcloud, Dexcom, Abbott, AstraZeneca, and Bayer
PlexusDx recommends spacing injections at least four weeks apart per site to allow full tissue recovery and maintain optimal therapeutic outcomes across your weight loss therapy
It also reduces the amount of sugar released by the liver
Heres how it works: Appetite Control GLP1 injections stimulate the brains appetite-regulating centers, leading to decreased hunger
Systemic injection for retinal benefits lacks human trial validation